Quest Clinical Research (United States)
- Research works
- 61 ▼ 50% vs 2013–17
- Citations
- 1.9k 30.6 per fractional work
- Top-10% rate
- 11.6% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: Quest Clinical Research (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.1×. Every wedge is a field page.
- Immunology and Microbiology 10.1×
- Psychology 3.9×
- Economics, Econometrics and Finance 3.0×
- Medicine 2.5×
- Computer Science 1.7×
- Arts and Humanities 1.5×
- Earth and Planetary Sciences 0.4×
- Neuroscience 0.3×
- Health Professions 0.3×
- Environmental Science 0.3×
- Social Sciences 0.2×
- Biochemistry, Genetics and Molecular Biology 0.2×
Who are the top researchers at Quest Clinical Research (United States)?
Ranked on the composite score, Jacob Lalezari lead among researchers whose main affiliation is Quest Clinical Research (United States).
- 1 Jacob Lalezari United States · #270,965 worldwide 89 citations · 29 works
Which keywords describe research at Quest Clinical Research (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Antiretroviral Therapy, HIV Infection, Immune Response, Adverse Effects, HIV, Drug Resistance, Hepatotoxicity and Integrase Inhibitors.
- Asthma
- Chronic Lymphocytic Leukemia
- Prognostic Factors
- Metabolic Abnormalities
- Bone Mineral Density
- Hepatitis C Virus
- Preexposure Prophylaxis
- Genetic Variation
- Liver Disease
- Gas Flaring
- Health Effects
- Antiviral Therapy
- AIDS
- Sustainability
- Vaccine
- Nucleoside Analogues
- Hepatotoxicity
- Drug Resistance
- Immune Response
- Epidemiology
- Antiretroviral Therapy
- HIV Infection
- Adverse Effects
- HIV
- Integrase Inhibitors
- Treatment
- Inflammation
- Antibodies
- Immune Activation
- Environmental Impact
- Black Carbon Emissions
- Therapeutic Targets
- Insulin Resistance
- HIV Transmission
- Aging
- Ribavirin
- Lipodystrophy
- Myocardial Infarction
- Rituximab
- Genomic Aberrations
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antiretroviral Therapy14▲ 97×5 topics
- Epidemiology8▲ 3.2×26 topics
- HIV Infection7▲ 91×2 topics
- Immune Response7▲ 18×7 topics
- Adverse Effects5▲ 107×2 topics
- Drug Resistance5▲ 27×2 topics
- HIV5▲ 72×4 topics
- Hepatotoxicity5▲ 114×2 topics
- Integrase Inhibitors5▲ 201×1 topic
- Nucleoside Analogues5▲ 201×1 topic
- Treatment5▲ 6.0×10 topics
- Vaccine5▲ 19×6 topics
- Inflammation4▲ 3.1×18 topics
- Sustainability4▲ 4.0×7 topics
- Antibodies4▲ 78×2 topics
- AIDS4▲ 127×1 topic
- Immune Activation4▲ 72×1 topic
- Antiviral Therapy3▲ 32×3 topics
- Environmental Impact3▲ 3.7×3 topics
- Health Effects3▲ 7.8×4 topics
- Black Carbon Emissions2▲ 704×1 topic
- Gas Flaring2▲ 704×1 topic
- Therapeutic Targets2▲ 16×4 topics
- Liver Disease2▲ 26×3 topics
- Insulin Resistance2▲ 7.1×3 topics
- Genetic Variation2▲ 9.7×2 topics
- HIV Transmission2▲ 37×1 topic
- Preexposure Prophylaxis2▲ 57×1 topic
- Aging2▲ 5.7×2 topics
- Hepatitis C Virus2▲ 55×1 topic
- Ribavirin2▲ 55×1 topic
- Bone Mineral Density2▲ 33×2 topics
- Lipodystrophy2▲ 129×1 topic
- Metabolic Abnormalities2▲ 129×1 topic
- Myocardial Infarction2▲ 11×2 topics
- Prognostic Factors2▲ 6.2×2 topics
- Rituximab2▲ 18×2 topics
- Chronic Lymphocytic Leukemia2▲ 53×1 topic
- Genomic Aberrations2▲ 53×1 topic
- Asthma2▲ 19×2 topics
Which research topics does Quest Clinical Research (United States) publish most on?
By volume in 2022–2025: Creativity in Education and Neuroscience, HIV/AIDS drug development and treatment, Cervical Cancer and HPV Research and Engineering Education and Technology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Creativity in Education and Neuroscience Experimental and Cognitive Psychology 0 works
- 2 HIV/AIDS drug development and treatment Infectious Diseases 0 works
- 3 Cervical Cancer and HPV Research Epidemiology 0 works
- 4 Engineering Education and Technology Information Systems 0 works
- 5 HIV Research and Treatment Virology 0 works
- 6 Healthcare Systems and Public Health Epidemiology 0 works
- 7 Digital Transformation in Law General Economics, Econometrics and Finance 0 works
- 8 Educational Innovations and Challenges Information Systems 0 works
- 9 HIV/AIDS Research and Interventions Infectious Diseases 0 works
- 10 Hepatitis C virus research Hepatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Quest Clinical Research (United States)'s research output changed?
Output in 2018–2022 was 50% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Francisco
- University of California, San Francisco
- San Francisco State University
- University of San Francisco
- San Francisco VA Medical Center
- University of California San Francisco Medical Center
- San Francisco General Hospital
- Institute on Aging
- California Pacific Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.